Skip to main content
letter
. 2014 Oct 28;86(6):702–704. doi: 10.1136/jnnp-2014-308625

Table 1.

Clinical findings in family members with the KIF5A mutation

I:2 II:1 II:4 II:5 II:6 III:1 III:4 III:5 III:7 III:8 III:10
Sex F F M F M F M F M M M
Age at examination 77 58 54 49 43 40 31 28 25 21 19
Age at onset* 55 49 51 39 36 32 26 18 21 16 12
Disease duration (years) 22 9 3 10 7 8 5 10 4 5 7
Disability stage† 2 2 2 3 2 3 3 4 3 3 3
SPRS‡ 14 16 16 21 18 25 26 38 26 25 28
LL pyramidal weakness + + + + + ++ ++ ++ ++ ++ ++
LL hyper-reflexia + + ++ ++ + + ++ ++ ++ ++ ++
LL spasticity + + + + + ++ + ++ ++ + ++
Babinski reflex +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+
Pes cavus +
Sensory deficits + + + +
VV R/L R/L L R/L R/L R/L L R R/L L R/L
VV stage§ (affected or worst side) C2 C2 C4a C2 C2 C6 C4b C4a C3 C3 C2
Bilateral DD + + + + + + + + + + +
DD stage¶ (worst side) 1 1 2 N 1 3 3 2 4 3 3
Sphincter disturbances + + + + + + +

*Age at onset was calculated approximately as the time when difficulty in walking first appeared in the affected individuals.

†Disability stages: 1, no mobility problems or slight stiffness of the legs; 2, moderate gait stiffness; 3, problems running, but able to walk alone; 4, problems walking; 5, wheelchair user.

‡SPRS, Spastic Paraplegia Rating Scale.2

§Clinical section from CEAP classification of chronic venous disease4: C0, no visible or palpable signs of venous disease; C1, telangiectasies or reticular veins; C2, varicose veins; C3, oedema; C4a, pigmentation or eczema; C4b, lipodermatosclerosis or atrophie blanche; C5, healed venous ulcer; C6, active venous ulcer.

¶Tubiana classification5: 0, no lesion; N, palmar nodule without the presence of contracture; 1, TFD between 0° and 45°; 2, TFD between 45° and 90°; 3, TFD between 90° and 135°; 4, TFD greater than 135°.

+ and −, indicate the presence and absence of a feature, respectively; DD, Dupuytren's disease; F, female; L, left leg; LL, lower limbs; M, male; R, right leg; TFD, total flexion deformity; VV, varicose veins.